Vaxcyte (PCVX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Vaxcyte (PCVX) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Vaxcyte

· PCVX

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

8.436 B

-1.49%

General

Market Cap: $8.44B
Enterprise Value: $8.03B
Shares Outstanding: 144,400,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -33.91%
ROE: -37.57%
ROIC: -40.55%
Current Ratio: 5.72
Debt-to-Equity: 0.04
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.09
P/S: —
P/FCF: —
P/B: 2.93
EV/EBITDA: -7.63

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $1.16B
Operating Income: -$1.17B
Net Profit: -$1.06B

Balance Sheet

Cash and Equivalents: $183.19M
Working Capital: $1.28B
Total Assets: $3.14B
Net Debt: -$67.75M
Total Liabilities: $380.21M
Total Equity: $2.76B

Cash Flow Statement (TTM)

Cash Flow from Operations: -$1.16B
Cash Flow from Investing: -$82.81M
Cash Flow from Financing: $1.21B
Free Cash Flow: -$1.2B
Capital Expenditures: $40.64M